Päivi Miettunen

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Angelo Ravelli, Francesca Minoia, Sergio Davì et al. · Arthritis & Rheumatology · 2015 · 771 citations · Full text

Life Sciences, Immunology, Autoimmunity +12

Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series

Peter A. Nigrović, Melissa L. Mannion, Femke H. M. Prince et al. · Arthritis & Rheumatism · 2010 · 464 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Francesca Minoia, Sergio Davì, AnnaCarin Horne et al. · Arthritis & Rheumatology · 2014 · 430 citations · Full text

Medicine, Hematology, Pathology +15

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Angelo Ravelli, Francesca Minoia, Sergio Davì et al. · Annals of the Rheumatic Diseases · 2016 · 397 citations

Medicine, Clinical Sciences, Immunology +10

The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

Jaime Guzmán, Kiem Oen, Lori B. Tucker et al. · Annals of the Rheumatic Diseases · 2014 · 266 citations

Medicine, Clinical Sciences, Pediatrics +13